Swiss National Bank Cuts Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Swiss National Bank reduced its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 4.8% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 562,600 shares of the medical device company's stock after selling 28,300 shares during the quarter. Swiss National Bank owned approximately 0.28% of Cooper Companies worth $51,720,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Byrne Asset Management LLC purchased a new position in Cooper Companies during the 4th quarter valued at $33,000. OFI Invest Asset Management purchased a new stake in Cooper Companies during the 4th quarter valued at about $34,000. Covestor Ltd grew its position in Cooper Companies by 144.9% during the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company's stock valued at $37,000 after purchasing an additional 200 shares during the last quarter. Brown Brothers Harriman & Co. grew its position in Cooper Companies by 191.0% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company's stock valued at $46,000 after purchasing an additional 275 shares during the last quarter. Finally, West Financial Advisors LLC bought a new position in Cooper Companies during the 4th quarter valued at about $49,000. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Trading Up 0.1 %

COO traded up $0.08 during trading on Wednesday, reaching $80.12. The company had a trading volume of 2,779,841 shares, compared to its average volume of 1,271,113. The Cooper Companies, Inc. has a 52 week low of $77.05 and a 52 week high of $112.38. The stock has a market cap of $16.02 billion, a P/E ratio of 41.09, a PEG ratio of 2.25 and a beta of 1.02. The business has a 50 day simple moving average of $90.68 and a 200-day simple moving average of $98.56. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32.

Remove Ads

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. On average, equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

COO has been the topic of several research analyst reports. Stifel Nicolaus lowered their target price on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. Wells Fargo & Company increased their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the company an "overweight" rating in a report on Friday, December 6th. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Finally, Robert W. Baird cut their target price on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to MarketBeat, Cooper Companies presently has a consensus rating of "Moderate Buy" and an average target price of $111.89.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.